Last reviewed · How we verify
placebo - isotonic saline serum
placebo - isotonic saline serum is a Small molecule drug developed by CHU de Reims. It is currently FDA-approved for Placebo control in clinical trials.
Isotonic saline serum serves as a physiologically balanced control or vehicle with no active pharmacological mechanism.
Isotonic saline serum serves as a physiologically balanced control or vehicle with no active pharmacological mechanism. Used for Placebo control in clinical trials.
At a glance
| Generic name | placebo - isotonic saline serum |
|---|---|
| Sponsor | CHU de Reims |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Isotonic saline (0.9% sodium chloride) is an inert solution that matches the osmotic pressure of blood and body fluids, making it suitable for intravenous or topical administration without causing cellular damage. As a placebo, it provides a chemically and osmotically neutral comparator in clinical trials. It has no intended therapeutic mechanism beyond maintaining fluid balance and serving as a delivery vehicle.
Approved indications
- Placebo control in clinical trials
Common side effects
- Injection site reactions (if administered parenterally)
- Fluid overload (with excessive volume)
Key clinical trials
- Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1) (PHASE1)
- Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis (PHASE2)
- Management of Pain in Lumbar Arthrodesis (PHASE4)
- Corticosteroid Meniscectomy Randomized Trial (PHASE4)
- Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia (PHASE2)
- The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis (PHASE2)
- Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome (PHASE2)
- TReatment for ImmUne Mediated PathopHysiology (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- placebo - isotonic saline serum CI brief — competitive landscape report
- placebo - isotonic saline serum updates RSS · CI watch RSS
- CHU de Reims portfolio CI
Frequently asked questions about placebo - isotonic saline serum
What is placebo - isotonic saline serum?
How does placebo - isotonic saline serum work?
What is placebo - isotonic saline serum used for?
Who makes placebo - isotonic saline serum?
What development phase is placebo - isotonic saline serum in?
What are the side effects of placebo - isotonic saline serum?
Related
- Manufacturer: CHU de Reims — full pipeline
- Indication: Drugs for Placebo control in clinical trials
- Compare: placebo - isotonic saline serum vs similar drugs
- Pricing: placebo - isotonic saline serum cost, discount & access